Stockscreener 앱 받기
63.59
2.15%
1.34
시간 외 거래:
63.59
전일 마감가:
$62.25
열려 있는:
$63.14
하루 거래량:
2.46M
Relative Volume:
1.09
시가총액:
$7.61B
수익:
$18.47M
순이익/손실:
$-589.53M
주가수익비율:
-12.09
EPS:
-5.26
순현금흐름:
$-399.80M
1주 성능:
+9.96%
1개월 성능:
+15.70%
6개월 성능:
+48.44%
1년 성능:
+24.69%
1일 변동 폭
$61.69
$63.99
1주일 범위
$57.83
$64.13
52주 변동 폭
$29.31
$64.13
Cytokinetics Inc Stock (CYTK) Company Profile
명칭
Cytokinetics Inc
전화
(650) 624-3000
주소
350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
CYTK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYTK
Cytokinetics Inc
|
63.59 | 7.45B | 18.47M | -589.53M | -399.80M | -5.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cytokinetics Inc Stock (CYTK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 재개 | Raymond James | Mkt Perform |
| 2025-04-24 | 개시 | Barclays | Overweight |
| 2025-02-07 | 개시 | Citigroup | Buy |
| 2025-01-22 | 개시 | Stifel | Buy |
| 2024-11-08 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-01-24 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-09 | 개시 | Goldman | Buy |
| 2023-11-07 | 개시 | B. Riley Securities | Buy |
| 2023-08-15 | 개시 | SVB Securities | Outperform |
| 2023-02-17 | 개시 | BofA Securities | Neutral |
| 2022-12-23 | 재확인 | Needham | Buy |
| 2022-12-20 | 개시 | Truist | Buy |
| 2022-10-11 | 개시 | UBS | Buy |
| 2022-01-28 | 개시 | Goldman | Buy |
| 2021-12-22 | 개시 | Oppenheimer | Outperform |
| 2021-12-10 | 개시 | JP Morgan | Overweight |
| 2021-10-07 | 개시 | Jefferies | Buy |
| 2021-03-12 | 개시 | Wolfe Research | Outperform |
| 2021-02-18 | 개시 | Barclays | Overweight |
| 2021-01-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-29 | 개시 | Goldman | Neutral |
| 2020-07-10 | 개시 | Raymond James | Strong Buy |
| 2020-05-05 | 개시 | Mizuho | Buy |
| 2020-04-09 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-09-10 | 재개 | Morgan Stanley | Equal-Weight |
| 2017-11-22 | 재확인 | Morgan Stanley | Overweight |
| 2017-11-22 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2017-11-21 | 재확인 | H.C. Wainwright | Buy |
| 2017-07-31 | 개시 | Morgan Stanley | Overweight |
| 2017-03-08 | 개시 | Rodman & Renshaw | Buy |
| 2017-02-06 | 업그레이드 | Needham | Buy → Strong Buy |
| 2016-12-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2016-07-28 | 재확인 | Needham | Buy |
| 2015-11-10 | 재확인 | FBR Capital | Outperform |
| 2015-11-09 | 재확인 | ROTH Capital | Buy |
| 2015-07-24 | 재확인 | MLV & Co | Buy |
| 2014-12-31 | 재확인 | ROTH Capital | Buy |
| 2014-11-04 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-04-28 | 재확인 | Needham | Buy |
모두보기
Cytokinetics Inc 주식(CYTK)의 최신 뉴스
Key facts: Cytokinetics' stock drops 12.98% after FDA delay; lawsuit filed - TradingView
What MACD and RSI say about Cytokinetics Incorporated2025 Institutional Moves & Weekly High Potential Alerts - newser.com
Cytokinetics Incorporated recovery potential after sell off2025 Big Picture & Real-Time Volume Surge Alerts - newser.com
Pinnacle Associates Ltd. Reduces Stock Holdings in Cytokinetics, Incorporated $CYTK - MarketBeat
Key metrics from Cytokinetics Incorporated’s quarterly dataFed Meeting & Low Drawdown Trading Strategies - newser.com
Why analysts remain bullish on Cytokinetics Incorporated stockMarket Movers & AI Enhanced Execution Alerts - newser.com
Is Cytokinetics Incorporated stock positioned for long term growthPortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Key facts: Cytokinetics shares fall 12.98% amid FDA delay; lawsuit filed - TradingView
Does Cytokinetics Incorporated qualify in momentum factor screeningJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
Cytokinetics (NASDAQ:CYTK) Reaches New 1-Year HighHere's Why - MarketBeat
Robert Blum Sells 5,000 Shares of Cytokinetics (NASDAQ:CYTK) Stock - MarketBeat
ROSEN, A LEADING AND RANKED FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, A LEADING AND RANKED FIRM, Encourages Cytokinetics, - GlobeNewswire
Cytokinetics, Inc. Hits New 52-Week High at USD 64.13 - Markets Mojo
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
Cytokinetics Announces Upcoming Late Breaking Science Presentations on Aficamten at Major Cardiovascular Conferences - Quiver Quantitative
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical ... - nrtoday.com
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025 - Yahoo Finance
Can Cytokinetics Incorporated (KK3A) stock test all time highs2025 Stock Rankings & Community Consensus Stock Picks - newser.com
How sentiment analysis helps forecast Cytokinetics IncorporatedMarket Performance Recap & Weekly Stock Performance Updates - newser.com
How Cytokinetics Incorporated stock benefits from strong dollar2025 AllTime Highs & Intraday High Probability Alerts - newser.com
Analyzing recovery setups for Cytokinetics Incorporated investorsJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - newser.com
What dividend safety score for Cytokinetics Incorporated stock2025 Volume Leaders & Smart Allocation Stock Tips - newser.com
Applying Elliott Wave Theory to Cytokinetics IncorporatedJuly 2025 Catalysts & Long-Term Capital Growth Strategies - newser.com
Is Cytokinetics Incorporated stock a smart buy before Fed meetingJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com
How to track smart money flows in Cytokinetics IncorporatedQuarterly Portfolio Report & AI Enhanced Execution Alerts - newser.com
Blum, Cytokinetics CEO, sells $314k in stock By Investing.com - Investing.com Australia
Cytokinetics stock hits 52-week high at 63.87 USD By Investing.com - Investing.com Canada
Investors SueWallSt as Cytokinetics, Incorporated Faces Securities Fraud Allegations - Nasdaq
Blum, Cytokinetics CEO, sells $314k in stock - Investing.com
Cytokinetics (CYTK): Exploring Valuation After Recent Share Price Momentum and Growth Narrative - Yahoo Finance
Cytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law ... - Caledonian Record
Deadline Alert: Cytokinetics, Incorporated (CYTK) - GlobeNewswire
Deadline Alert: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Cytokinetics stock hits 52-week high at 63.87 USD - Investing.com
Cytokinetics (CYTK) to Release Earnings on Wednesday - MarketBeat
Cytokinetics, Incorporated $CYTK Shares Bought by State of New Jersey Common Pension Fund D - MarketBeat
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - GlobeNewswire Inc.
CYTOKINETICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urgently Reminds CYTK ... - Bluefield Daily Telegraph
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit - Barchart.com
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FinancialContent
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics - MarketScreener
Earnings Preview: Cytokinetics (CYTK) Q3 Earnings Expected to Decline - Yahoo Finance
Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Cytokinetics Shareholder Alert By Former Louisiana Attorney - GlobeNewswire
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - GlobeNewswire Inc.
Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments - CNBC
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, ... - Bluefield Daily Telegraph
Investors in Cytokinetics, Incorporated Should Contact Levi - GlobeNewswire
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure ... - Bluefield Daily Telegraph
Cytokinetics Inc (CYTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):